Recent insider trading in HAYWARD, California

Date
#
Company
Insider Title
Trans.
Transaction
Shares Price per share Total price Shares after Source
2017-12-26 Ronald D'ercole
SVP, Quality
SVP, Quality Sale 3,009 $21.41 $64,422.69
2017-12-26
55,900 SEC insider form 4
2017-12-15 David T Ibnale
Director
Director Sale 12,500 $21.58 $269,750.00
2017-12-15
63,500 SEC insider form 4
2017-12-13 Maky Zanganeh
Director
Director Buy 1,100 $23.98 $26,378.00
2017-12-13
95,574 SEC insider form 4
2017-12-11 Maky Zanganeh
Director
Director Buy 4,000 $23.07 $92,280.00
2017-12-11
94,474 SEC insider form 4
2017-11-28 Joan Sterling
SVP, Human Resources
SVP, Human Resources Sale 5,202 $24.04 $125,056.08
2017-11-28
64,932 SEC insider form 4
2017-10-31 William Joe Williams
SVP, Customer Business Mgmt
SVP, Customer Business Mgmt Sale 10,404 $24.50 $254,898.00
2017-10-31
91,543 SEC insider form 4
2017-10-31 Ronald D'ercole
SVP, Quality
SVP, Quality Sale 5,202 $24.49 $127,396.98
2017-10-31
60,900 SEC insider form 4
2017-10-25 Deborah E Hayward
Please see Remarks
Please see Remarks Sale 13,872 $32.48 $450,562.56
2017-10-25
53,102 SEC insider form 4
2017-09-29 Ronald D'ercole
SVP, Quality
SVP, Quality Sale 1,457 $30.47 $44,394.79
2017-09-29
69,233 SEC insider form 4
2017-09-28 Christopher S Henney
Director
Director Option exercise 900 $6.65 $5,985.00
2017-09-28
900 SEC insider form 4
2017-09-24 Christopher S Henney
Director
Director Option exercise 2,375 $0.00 $0.00
2017-09-24
60,779 SEC insider form 4
2017-09-20 John Craig Thompson
President & CEO
President & CEO Buy 8,550 $1.32 $11,286.00
2017-09-20
19,848 SEC insider form 4
2017-09-14 Maky Zanganeh
Director
Director Buy 29,775 $13.36 $397,794.00
2017-09-14
332,500 SEC insider form 4
2017-09-12 David Speirs
SVP, North America
SVP, North America Sale 19,029 $24.04 $457,457.16
2017-09-12
100,879 SEC insider form 4
2017-09-07 Paul F Truex
Buy 5,000 $1.34 $6,700.00
2017-09-07
16,793 SEC insider form 4
2017-09-07 John Craig Thompson
President & CEO
President & CEO Option exercise 10,400 $1.43 $14,872.00
2017-09-07
17,590 SEC insider form 4
2017-09-06 David T Ibnale
Director
Director Sale 10,000 $22.95 $229,500.00
2017-09-06
76,000 SEC insider form 4
2017-08-02 Maky Zanganeh
Director
Director Buy 28,790 $23.96 $689,808.40
2017-08-02
90,474 SEC insider form 4
2017-08-01 Sheri Brumm
CFO, SVP Finance and Secretary
CFO, SVP Finance and Secretary Sale 20,512 $22.85 $468,699.20
2017-08-01
168,974 SEC insider form 4
2017-07-27 Mark Bingaman
SVP, Supply Chain
SVP, Supply Chain Sale 121 $25.02 $3,027.42
2017-07-27
76,094 SEC insider form 4
2017-07-17 Christopher S Henney
Director
Director Option exercise 5,000 $6.65 $33,250.00
2017-07-17
5,000 SEC insider form 4
2017-06-24 Christopher S Henney
Director
Director Option exercise 9,058 $0.00 $0.00
2017-06-24
60,669 SEC insider form 4
2017-06-22 Brian Mueller
SVP, Corporate Controller
SVP, Corporate Controller Option exercise 2,671 $21.51 $57,453.21
2017-06-22
15,556 SEC insider form 4
2017-06-19 Michael Roy Henderson
SVP, Engineering
SVP, Engineering Sale 10,425 $21.00 $218,925.00
2017-06-19
43,272 SEC insider form 4
2017-06-15 Deborah E Hayward
Please see Remarks
Please see Remarks Sale 19,883 $20.76 $412,771.08
2017-06-15
66,974 SEC insider form 4
2017-06-09 Christopher S Henney
Director
Director Option exercise 2,148 $0.00 $0.00
2017-06-09
52,148 SEC insider form 4
2017-06-08 Emily M Liggett
Director
Director Sale 6,000 $25.00 $150,000.00
2017-06-08
17,500 SEC insider form 4
2017-06-05 Mark Bingaman
SVP, Supply Chain
SVP, Supply Chain Sale 36,743 $23.34 $857,581.62
2017-06-05
76,670 SEC insider form 4
2017-05-31 Emily M Liggett
Director
Director Sale 4,000 $22.66 $90,640.00
2017-05-31
23,500 SEC insider form 4
2017-05-31 Ronald D'ercole
SVP, Quality
SVP, Quality Sale 18,608 $22.67 $421,843.36
2017-05-31
71,566 SEC insider form 4
2017-05-31 Michael Nestor
President, Impax Pharm.
President, Impax Pharm. Sale 1,130 $15.00 $16,950.00
2017-05-31
106,943 SEC insider form 4
2017-05-25 Leonid Mezhvinsky
Director
Director Sale 6,800 $23.26 $158,168.00
2017-05-25
33,500 SEC insider form 4
2017-05-17 Michael Nestor
President, Impax Pharm.
President, Impax Pharm. Sale 857 $16.48 $14,123.36
2017-05-17
108,073 SEC insider form 4
2017-05-12 Michael Nestor
President, Impax Pharm.
President, Impax Pharm. Sale 700 $17.11 $11,977.00
2017-05-12
115,168 SEC insider form 4
2017-05-09 Maky Zanganeh
Director
Director Buy 53,760 $20.49 $1,101,542.40
2017-05-09
85,474 SEC insider form 4
2017-05-03 Emily M Liggett
Director
Director Sale 13,000 $20.87 $271,310.00
2017-05-03
20,000 SEC insider form 4
2017-05-02 Leonid Mezhvinsky
Director
Director Sale 23,200 $20.43 $473,976.00
2017-05-02
32,800 SEC insider form 4
2017-04-28 Brian Mueller
SVP, Corporate Controller
SVP, Corporate Controller Sale 7,482 $91.87 $687,371.34
2017-04-28
13,468 SEC insider form 4
2017-04-26 Mark Bingaman
SVP, Supply Chain
SVP, Supply Chain Sale 170 $17.75 $3,017.50
2017-04-26
103,475 SEC insider form 4
2017-04-04 Juergen Kurt Froehlich
Chief Medical Officer
Chief Medical Officer Sale 3,765 $1.51 $5,685.15
2017-04-04
85,129 SEC insider form 4
2017-04-03 Deborah E Hayward
Please see Remarks
Please see Remarks Sale 7,912 $16.58 $131,180.96
2017-04-03
76,919 SEC insider form 4
2017-03-31 Mark Bingaman
SVP, Supply Chain
SVP, Supply Chain Sale 7,981 $16.43 $131,127.83
2017-03-31
104,283 SEC insider form 4
2017-03-31 Lavi Lev
President, Asia
President, Asia Sale 23,507 $16.43 $386,220.01
2017-03-31
79,691 SEC insider form 4
2017-03-17 Maky Zanganeh
Director
Director Buy 18,240 $23.34 $425,721.60
2017-03-17
46,714 SEC insider form 4
2017-03-17 David Speirs
SVP, North America
SVP, North America Option exercise 10,000 $14.90 $149,000.00
2017-03-17
153,716 SEC insider form 4
2017-03-17 Deborah E Hayward
Please see Remarks
Please see Remarks Option exercise 30,000 $14.90 $447,000.00
2017-03-17
114,831 SEC insider form 4
2017-03-02 Joan Sterling
SVP, Human Resources
SVP, Human Resources Sale 17,343 $13.85 $240,200.55
2017-03-02
56,765 SEC insider form 4
2017-03-01 David Speirs
SVP, North America
SVP, North America Sale 44,129 $15.11 $666,789.19
2017-03-01
103,791 SEC insider form 4
2017-03-01 Deborah E Hayward
Please see Remarks
Please see Remarks Sale 17,778 $13.93 $247,647.54
2017-03-01
84,831 SEC insider form 4
2017-03-01 Sheri Brumm
CFO, SVP Finance and Secretary
CFO, SVP Finance and Secretary Sale 6,492 $13.92 $90,368.64
2017-03-01
179,552 SEC insider form 4
Messenger